TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive In Brief: Senate Committee Confirms Varmus; Albertini Directs Vermont Cancer Center November 19, 1993